Dr Marsden ND

03/03/2026

A new EFSA report shows that many people are eating more fish — but awareness about mercury exposure and safe choices is still low.

This is especially important for:
🤰 Pregnant women
👶 Children

The solution isn’t avoiding fish — it’s choosing wisely.

We recommend:
✔ 2–3 servings per week of low-mercury fish
✔ Choose wild-caught salmon, sardines, anchovies, trout, and Atlantic mackerel
❌ Limit high-mercury fish like swordfish, shark, king mackerel, and bigeye tuna

Fish provides essential omega-3 fats that support brain development — particularly during pregnancy and childhood. The key is informed selection, not elimination.

Read more: https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2026.9865

02/28/2026

When you hear “cancer prevention,” do you think of sleep, nutrition, and exercise? You’re not wrong—but in 2026, prevention is so much more.

Today, we’re entering an era of precision medicine, where prevention means:
• Tracking key inflammatory markers
• Understanding your unique genetic and family risks
• Monitoring metabolic health in real time
• Leveraging cutting-edge early-detection technologies

It’s time to move beyond one-size-fits-all advice. Prevention is now about creating personalized, patient-centered plans that address their individual risk—before symptoms ever appear.

The real question isn’t “Am I healthy?”
It’s “What’s happening beneath the surface—and how can we act now?”

Curious how precision prevention could work for you? Drop a “PREVENTION” in the comments to start the conversation.

02/07/2026

Elevated cholesterol is not a single-pathway condition.

In clinical practice, we frequently see lipid abnormalities driven by insulin resistance, chronic inflammation, impaired bile acid metabolism, gut microbiome imbalance, dietary fiber insufficiency, hormonal factors, and genetic predisposition.

Management options discussed in this video include:
• Dietary pattern optimization
• Specific fiber types with LDL-lowering effects
• Microbiome-supportive strategies
• Select nutraceuticals with clinical evidence
• Advanced lipid, inflammatory, and metabolic testing

A comprehensive, individualized strategy allows for more precise risk reduction—often alongside conventional therapy when indicated.

02/05/2026

Cancer treatment is not one-size-fits-all.

Integrative cancer care focuses on the whole person—combining standard oncology with evidence-informed strategies to support symptom management, quality of life, resilience, and long-term health.

On World Cancer Day, we reflect on the importance of patient-centred care that respects individual needs, values, and goals—alongside conventional treatment.

Care works best when patients are supported, informed, and truly seen.

01/17/2026

Men’s health requires more than symptom management. It demands a proactive, personalized, and evidence-informed approach.

This event will explore advanced assessment tools and integrative strategies that support hormonal balance, cardiometabolic health, performance, and long-term disease prevention.

If you’re a clinician looking to elevate your approach to men’s health, this is a conversation you won’t want to miss.

🔗 Registration link in the comments ⬇️

01/15/2026

Traditional cardiac tests often look at how the heart functions.
Advanced imaging looks at what’s actually happening inside the arteries.

By identifying plaque early, we can intervene sooner, personalize care, and reduce long-term cardiovascular risk.
This is the future of preventive cardiology: precise, proactive, and personalized.

Full research article linked in comments ⬇️

01/08/2026

Such an important factor to be looking for in our patients when evaluating cardiometabolic risk. Don’t wait for the drugs to come out. Measure now so we can escalate other risk reduction strategies to improve patient outcomes.

Very high lipoprotein(a) levels are associated with increased 30-year risk of major events, coronary heart disease, ischemic , and cardiovascular death among healthy women.

https://ja.ma/4qKoDkc

01/07/2026

Mapping the Future: Next-Gen Tools for Personalized Cancer Care
🗓 January 14, 2026
Delivered free with Vitazan/NFH Integrative Oncology Series

Precision oncology is evolving rapidly—and so are the tools we use to guide care.

In this upcoming presentation, I’ll be exploring how advanced precision oncology assessment tools are reshaping:
🔬 Cancer screening & early detection
🧬 Diagnostic refinement & risk stratification
📊 Surveillance & minimal residual disease monitoring
🎯 Therapy selection & treatment response tracking

From molecular profiling and liquid biopsies to functional and metabolic assessments, we’ll look at how these technologies can be integrated into personalized, patient-centred cancer care—bridging conventional and integrative oncology approaches.

📌 Join me January 14 as we map where oncology is headed—and how clinicians can prepare now.

Register here: https://register.gotowebinar.com/register/6317651324404373085

01/07/2026

4
🔍 Cardiovascular biomarkers — from hs-CRP to advanced lipid subfractions — offer nuanced insights into cardiovascular risk that go far beyond LDL.
In this video, I talk about my favourite cardio markers and what tell us.
Check out more details on these and other important markers and how they can inform preventive care on my blog:
🔗 https://www.drmarsden.com/post/latest-trends-in-integrative-medicine-by-dr-marsden-nd

01/04/2026

Reflecting on 2025—and looking ahead to 2026.

This past year brought several important evidence shifts that meaningfully changed how I think about integrative care. In this video, I highlight four areas that stood out most:

• BHRT – strong evidence for safety and efficacy beyond vasomotor symptoms, including major regulatory changes
• The gut–brain–immune–endocrine axis – now firmly established as central to chronic disease
• Low-dose naltrexone (LDN) – growing evidence in long-haul viral illness, including Long COVID
• Physical activity in cancer care – not just supportive, but outcome-changing

If you’d like to go deeper, here is a link to a document in the caption where I review the research and clinical implications in more detail: https://www.drmarsden.com/post/integrative-approaches-to-holistic-healing-with-dr-marsden

Looking forward to continuing the conversation in 2026.

12/06/2025

Precision oncology assessments like ctDNA should be an essential part of a cancer patient”s care. Integrative oncology providers have known that off-label meds like celcoxib seem to help some patients more than others. With precision oncology assessments that look for cancer genomic variations or tests to assess mrd status we are beginning to figure out who will benefit most from these treatments.

We continue to wait for full coverage of this technology in Ontario for cancers that have good evidence for its efficacy. Until then, we encourage patients to access through clinical trial participation like this, through out of country OHIP funding, or order through members of our integrative MD/NP provider team.

ctDNA status may help identify which patients benefit from adjuvant celecoxib, supporting personalized treatment approaches in . https://ja.ma/48A59Hp